Perrigo wins FDA nod to market generic version of children's allergy syrup

09/10/2013 | Drug Store News

The FDA gave Perrigo its final approval on Tuesday to market the store-brand equivalent to Children's Zyrtec Allergy Syrup, an indoor/outdoor allergy drug for children aged 2 years and older. The company expects to start shipments of this generic version during the upcoming cough/cold/flu season.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID